| pubmed-article:10636232 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10636232 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
| pubmed-article:10636232 | lifeskim:mentions | umls-concept:C1519249 | lld:lifeskim |
| pubmed-article:10636232 | lifeskim:mentions | umls-concept:C0038477 | lld:lifeskim |
| pubmed-article:10636232 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
| pubmed-article:10636232 | lifeskim:mentions | umls-concept:C2267054 | lld:lifeskim |
| pubmed-article:10636232 | lifeskim:mentions | umls-concept:C0678594 | lld:lifeskim |
| pubmed-article:10636232 | lifeskim:mentions | umls-concept:C1328650 | lld:lifeskim |
| pubmed-article:10636232 | lifeskim:mentions | umls-concept:C0205549 | lld:lifeskim |
| pubmed-article:10636232 | lifeskim:mentions | umls-concept:C1707689 | lld:lifeskim |
| pubmed-article:10636232 | lifeskim:mentions | umls-concept:C1705938 | lld:lifeskim |
| pubmed-article:10636232 | lifeskim:mentions | umls-concept:C1527178 | lld:lifeskim |
| pubmed-article:10636232 | lifeskim:mentions | umls-concept:C0052323 | lld:lifeskim |
| pubmed-article:10636232 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:10636232 | pubmed:dateCreated | 2000-2-28 | lld:pubmed |
| pubmed-article:10636232 | pubmed:abstractText | A series of arginine aldehyde inhibitors was designed as transition state (TS) analogues based on the known factor Xa specific substrate Cbz-D-Arg-Gly-Arg-pNA. BnSO2-(D)Arg-Gly-Arg-H (20) was found to be the most potent and selective inhibitor of factor Xa and prothrombinase activity in this series. | lld:pubmed |
| pubmed-article:10636232 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10636232 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10636232 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10636232 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10636232 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10636232 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10636232 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10636232 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10636232 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10636232 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10636232 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10636232 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10636232 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10636232 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:10636232 | pubmed:issn | 0960-894X | lld:pubmed |
| pubmed-article:10636232 | pubmed:author | pubmed-author:SinhaUU | lld:pubmed |
| pubmed-article:10636232 | pubmed:author | pubmed-author:ScarboroughR... | lld:pubmed |
| pubmed-article:10636232 | pubmed:author | pubmed-author:MarloweC KCK | lld:pubmed |
| pubmed-article:10636232 | pubmed:author | pubmed-author:GunnA CAC | lld:pubmed |
| pubmed-article:10636232 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10636232 | pubmed:day | 3 | lld:pubmed |
| pubmed-article:10636232 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:10636232 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10636232 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10636232 | pubmed:pagination | 13-6 | lld:pubmed |
| pubmed-article:10636232 | pubmed:dateRevised | 2000-12-18 | lld:pubmed |
| pubmed-article:10636232 | pubmed:meshHeading | pubmed-meshheading:10636232... | lld:pubmed |
| pubmed-article:10636232 | pubmed:meshHeading | pubmed-meshheading:10636232... | lld:pubmed |
| pubmed-article:10636232 | pubmed:meshHeading | pubmed-meshheading:10636232... | lld:pubmed |
| pubmed-article:10636232 | pubmed:meshHeading | pubmed-meshheading:10636232... | lld:pubmed |
| pubmed-article:10636232 | pubmed:meshHeading | pubmed-meshheading:10636232... | lld:pubmed |
| pubmed-article:10636232 | pubmed:meshHeading | pubmed-meshheading:10636232... | lld:pubmed |
| pubmed-article:10636232 | pubmed:meshHeading | pubmed-meshheading:10636232... | lld:pubmed |
| pubmed-article:10636232 | pubmed:meshHeading | pubmed-meshheading:10636232... | lld:pubmed |
| pubmed-article:10636232 | pubmed:meshHeading | pubmed-meshheading:10636232... | lld:pubmed |
| pubmed-article:10636232 | pubmed:meshHeading | pubmed-meshheading:10636232... | lld:pubmed |
| pubmed-article:10636232 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10636232 | pubmed:articleTitle | Design, synthesis and structure-activity relationship of a series of arginine aldehyde factor Xa inhibitors. Part 1: structures based on the (D)-Arg-Gly-Arg tripeptide sequence. | lld:pubmed |
| pubmed-article:10636232 | pubmed:affiliation | COR Therapeutics, Inc., South San Francisco, CA 94080, USA. | lld:pubmed |
| pubmed-article:10636232 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:10636232 | lld:chembl |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10636232 | lld:pubmed |
